title: Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.
abstract: Toll-like receptors (TLRs) play a crucial role in the innate immune response and the subsequent induction of adaptive immune responses against microbial infection or tissue injury. Recent findings show that functional TLRs are expressed not only on immune cells but also on cancer cells. TLRs play an active role in carcinogenesis and tumor progression during chronic inflammation that involves the tumor microenvironment. Damage-associated molecular patterns (DAMPs) derived from injured normal epithelial cells and necrotic cancer cells appear to be present at significant levels in the tumor microenvironment, and their stimulation of specific TLRs can foster chronic inflammation. This review discusses how carcinogenesis, cancer progression, and site-specific metastasis are related to interactions between cancer cells, immune cells, and DAMPs through TLR activation in the tumor microenvironment.
authors.affiliation: Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Blvd., Santa Monica, CA, 90404, USA.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Sato
authors.forename: Yasufumi
authors.initials: Y
authors.lastname: Goto
authors.forename: Norihiko
authors.initials: N
authors.lastname: Narita
authors.forename: Dave S B
authors.initials: DS
authors.lastname: Hoon
references.citation: Clin Cancer Res. 2007 Dec 1;13(23):7119-25
references.pmid: 18056192
references.citation: PLoS Med. 2009 Jan 13;6(1):e10
references.pmid: 19143470
references.citation: Immunology. 2005 Aug;115(4):565-74
references.pmid: 16011525
references.citation: Cell Cycle. 2009 Feb 15;8(4):589-95
references.pmid: 19182519
references.citation: Gastroenterology. 2008 Aug;135(2):518-28
references.pmid: 18538140
references.citation: Int J Immunopharmacol. 1999 Jan;21(1):1-14
references.pmid: 10411278
references.citation: Nat Rev Cancer. 2005 Apr;5(4):263-74
references.pmid: 15776005
references.citation: Methods Mol Biol. 2006;336:123-34
references.pmid: 16916258
references.citation: Prostate. 2008 Feb 1;68(2):223-9
references.pmid: 18092352
references.citation: Int J Gynecol Cancer. 2008 Mar-Apr;18(2):300-5
references.pmid: 17587322
references.citation: Gastroenterology. 2007 Dec;133(6):1869-81
references.pmid: 18054559
references.citation: Int J Cancer. 2007 Oct 1;121(7):1433-44
references.pmid: 17565747
references.citation: Angiogenesis. 2008;11(1):91-9
references.pmid: 18264787
references.citation: Br J Cancer. 2005 Jun 6;92(11):1955-8
references.pmid: 15900299
references.citation: J Immunol. 2009 Feb 1;182(3):1469-80
references.pmid: 19155494
references.citation: Clin Cancer Res. 2008 Sep 1;14(17):5512-8
references.pmid: 18765543
references.citation: Nat Rev Cancer. 2009 Jan;9(1):57-63
references.pmid: 19052556
references.citation: Immunol Rev. 2008 Apr;222:180-91
references.pmid: 18364002
references.citation: Eur J Cancer. 2008 Sep;44(13):1875-82
references.pmid: 18617393
references.citation: J Biol Chem. 2004 Mar 26;279(13):12542-50
references.pmid: 14729660
references.citation: Cancer Res. 2006 Apr 1;66(7):3859-68
references.pmid: 16585214
references.citation: Clin Cancer Res. 2007 May 15;13(10):2836-48
references.pmid: 17504981
references.citation: Oncogene. 2008 Oct 6;27(45):5904-12
references.pmid: 18836471
references.citation: Int J Oncol. 2008 Nov;33(5):929-36
references.pmid: 18949355
references.citation: Int J Dermatol. 2005 Jan;44(1):14-9
references.pmid: 15663652
references.citation: Mol Cancer Res. 2006 Jul;4(7):437-47
references.pmid: 16849519
references.citation: Biol Pharm Bull. 2005 May;28(5):886-92
references.pmid: 15863899
references.citation: Cancer Immunol Immunother. 2009 Sep;58(9):1375-85
references.pmid: 19184006
references.citation: Cancer Res. 2003 Jul 15;63(14):3966-8
references.pmid: 12873992
references.citation: Science. 2004 Feb 6;303(5659):848-51
references.pmid: 14764882
references.citation: BMC Cancer. 2006 Dec 08;6:281
references.pmid: 17156435
references.citation: Oncogene. 2008 Jan 7;27(2):161-7
references.pmid: 18176597
references.citation: Front Biosci. 2008 Jan 01;13:453-61
references.pmid: 17981560
references.citation: Nature. 2008 Jul 24;454(7203):436-44
references.pmid: 18650914
references.citation: Br J Cancer. 2007 Sep 3;97(5):598-604
references.pmid: 17667928
references.citation: J Intern Med. 2000 Sep;248(3):171-83
references.pmid: 10971784
references.citation: Mol Cancer Ther. 2008 Nov;7(11):3642-53
references.pmid: 19001446
references.citation: Clin Cancer Res. 2006 Jan 15;12(2):577-83
references.pmid: 16428503
references.citation: BMC Immunol. 2008 Jul 24;9:39
references.pmid: 18652679
references.citation: Cancer Biol Ther. 2007 Nov;6(11):1704-9
references.pmid: 17986857
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4565-74
references.pmid: 17671143
references.citation: Biochem Biophys Res Commun. 2009 Feb 20;379(4):1027-32
references.pmid: 19141294
references.citation: Respir Res. 2005 Jan 04;6:1
references.pmid: 15631627
references.citation: Mol Med. 2008 Sep-Oct;14(9-10):645-59
references.pmid: 18584047
references.citation: Clin Cancer Res. 2008 May 15;14(10):2909-17
references.pmid: 18483357
references.citation: J Cell Biochem. 2007 Jul 1;101(4):805-15
references.pmid: 17226777
references.citation: Clin Cancer Res. 2008 Feb 1;14(3):856-64
references.pmid: 18245549
references.citation: Cancer Cell. 2004 Sep;6(3):297-305
references.pmid: 15380520
references.citation: Blood. 2003 Sep 1;102(5):1740-2
references.pmid: 12714497
references.citation: Clin Chem. 2002 Aug;48(8):1212-7
references.pmid: 12142376
references.citation: Pancreas. 1998 Jul;17(1):89-97
references.pmid: 9667526
references.citation: Oncology. 2005;69 Suppl 3:4-10
references.pmid: 16301830
references.citation: Cancer Res. 2005 Jan 15;65(2):465-72
references.pmid: 15695388
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9351-8
references.pmid: 16361635
references.citation: J Drugs Dermatol. 2005 Nov-Dec;4(6):708-17
references.pmid: 16302556
references.citation: Br J Cancer. 2004 Mar 22;90(6):1211-5
references.pmid: 15026803
references.citation: Immunity. 2008 Jul 18;29(1):12-20
references.pmid: 18631453
references.citation: Int J Med Microbiol. 2005 Jun;295(3):179-85
references.pmid: 16044857
references.citation: J Drugs Dermatol. 2008 Jan;7(1 Suppl 1):s7-14
references.pmid: 18277457
references.citation: Immunol Rev. 2007 Dec;220:60-81
references.pmid: 17979840
references.citation: Nat Cell Biol. 2008 Nov;10(11):1349-55
references.pmid: 18820689
references.citation: Nature. 2004 Sep 23;431(7007):461-6
references.pmid: 15329734
references.citation: Eur Arch Otorhinolaryngol. 2007 May;264(5):525-30
references.pmid: 17165086
references.citation: Immunol Res. 2005;32(1-3):155-68
references.pmid: 16106066
references.citation: Mol Carcinog. 2007 Nov;46(11):941-7
references.pmid: 17440926
references.citation: Prostate. 2007 May 15;67(7):774-81
references.pmid: 17373717
references.citation: Mol Immunol. 2007 Apr;44(11):2850-9
references.pmid: 17328955
references.citation: Cancer Immunol Immunother. 1989;29(2):133-8
references.pmid: 2720706
references.citation: Immunol Rev. 2008 Apr;222:162-79
references.pmid: 18364001
references.citation: Biochem Soc Trans. 2007 Dec;35(Pt 6):1473-8
references.pmid: 18031248
references.citation: J Infect Chemother. 2008 Apr;14(2):86-92
references.pmid: 18622669
references.citation: J Biol Chem. 2004 Feb 13;279(7):5405-12
references.pmid: 14645242
references.citation: J Immunol. 2009 Jan 1;182(1):240-9
references.pmid: 19109155
references.citation: J Immunol. 2005 Dec 15;175(12):8242-52
references.pmid: 16339564